EX-10.2 3 rlyp-ex102_513.htm EX-10.2 EXECUTION VERSIONDetailing Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
DETAILING AGREEMENT between sanofi-aventis US LLC and Relypsa, Inc. Dated as of August 10, 2015Detailing Agreement • November 4th, 2015 • Relypsa Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 4th, 2015 Company Industry JurisdictionThis detailing agreement (the “Agreement”) is effective as of August 10, 2015 (the “Effective Date”) by and between Relypsa, Inc., a Delaware corporation located at 100 Cardinal Way, Redwood City, CA 94063, USA (“Relypsa”) and sanofi-aventis US LLC, a Delaware limited liability company located at 55 Corporate Drive, Bridgewater NJ 08807 (“Sanofi”). Relypsa and Sanofi are referred to individually as a “Party” and collectively as the “Parties”.